Two biologics companies in Indiana underwent FDA inspections during the first quarter of 2026, according to the U.S. Food and Drug Administration (FDA).
The FDA conducted the fewest inspections of any company type in Indiana during this period, with these two inspections representing 4% of all FDA inspections in the state in the first quarter of 2026.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 1 | — | — |
| Blood and Blood Products | 2 | — | — |
| Compliance: Devices | — | 5 | — |
| Drug Quality Assurance | 1 | 1 | — |
| Food Composition, Standards, Labeling and Econ | 7 | 1 | — |
| Foodborne Biological Hazards | 30 | 3 | — |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 6 | 1 | — |
| Postmarket Assurance: Devices | 1 | — | — |
